Leidos Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
5.1%projected annual EPS growth
Analyst Coverage
15analysts covering
FY Revenue (est.)
$18.3Bnext fiscal year
FY EPS (est.)
$12.39next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 6 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Consolidated Revenue Quarterly4.4BTarget: 18000000000 to 18400000000
Non-GAAP Diluted EPS Quarterly3.1Target: 12.10 to 12.50
Total Backlog Quarterly48.4BTarget: Sustained backlog expansion
Watch Items
- Defense Health Agency EHR Program RecompeteTrigger: Loss of primary systems integrator status or major contract shiftAction: Reassess long-term health segment revenue projections and adjust segment margin expectations.
- Veterans Administration Medical Exam Contract (VBA)Trigger: Uncertainty or reduction in high-margin medical exam volumesAction: Evaluate impact on consolidated operating margins and adjust cash flow forecasts.
Research as of 2 Sep 2026